Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination

Affiliations

¹ University of Connecticut School of Medicine, Farmington, Connecticut.
² Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.

Leelakrishna Channa et al. JAAD Case Rep. 2021 Sep.

. 2021 Sep:15:60-61.

doi: 10.1016/j.jdcr.2021.05.042. Epub 2021 Jul 22.

¹ University of Connecticut School of Medicine, Farmington, Connecticut.
² Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.

No abstract available

Conflict of interest statement

None disclosed.

1. Rodríguez-Jiménez P., Chicharro P., Cabrera L.M. Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Rep. 2021;12:58–59. doi: 10.1016/j.jdcr.2021.04.014. - DOI - PMC - PubMed
1. McMahon D.E., Amerson E., Rosenbach M. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46–55. doi: 10.1016/j.jaad.2021.03.092. - DOI - PMC - PubMed
1. Eid E., Abdullah L., Kurban M., Abbas O. Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol. 2021;93(9):5231–5232. doi: 10.1002/jmv.27036. - DOI - PMC - PubMed
1. Bostan E., Yalici-Armagan B. Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol. 2021;20(6):1566–1567. doi: 10.1111/jocd.14035. - DOI - PubMed
1. Furer V., Zisman D., Kibari A., Rimar D., Paran Y., Elkayam O. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford) April 12, 2021:keab345. doi: 10.1093/rheumatology/keab345. - DOI - PMC - PubMed